Počet záznamov: 1
klopidogrel
SYS d000077144 LBL 00000nz--a2200181n--4500 005 20250606222636.5 008 190101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 065 $a D02.886.778.823.500.500 065 $a D03.383.725.849.500.500 065 $a D03.383.903.830.500.500 065 $a D03.633.100.928.500.500 066 $a 01 $c 03 150 $a klopidogrel $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a klopidogrel bezilát $2 slo 450 $w v $a klopidogrel bezylát $2 slo 450 $w v $a klopidogrel bisulfát $2 slo 450 $w v $a klopidogrel hydrochlorid $2 slo 450 $w v $a klopidogrel napadisilát $2 slo 450 $w v $a Clopidogrel Sandoz $2 slo 450 $w v $a klopidogrel, (+)(S)-izomér $2 slo 450 $w v $a Clopidogrel-Mepha $2 slo 450 $w v $a Iscover $2 slo 450 $w v $a Plavix $2 slo 550 $7 sllk_us_auth*d010975 $Y Platelet Aggregation Inhibitors $w P $a inhibítory agregácie trombocytov 550 $7 sllk_us_auth*d058921 $Y Purinergic P2Y Receptor Antagonists $w P $a antagonisty purinergných receptorov P2Y 665 $a 2019 (1988) $2 eng 680 9-
$i A ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION. $2 eng 750 -2
$a Clopidogrel $2 eng 980 $x M
Počet záznamov: 1